Podcasts about Presbyopia

Presbyopia is a natural, age-related condition affecting 128 million worldwide, often addressed  with traditional solutions like reading glasses or progressive lenses. However, a groundbreaking  alternative is emerging: QLOSI™, a new presbyopia treatment featuring a 0.4% pilocarpine  hydrochloride ophthalmic solution.

In this insightful episode of the Focused Healthy Family podcast, Gina shines a light on the many vision challenges that come with aging. From the everyday nuisances of floaters and presbyopia (trouble focusing up close) to more serious conditions like cataracts, glaucoma, and conjunctivitis, she explores how these changes affect not only vision but also quality of life and independence for seniors. Gina shares helpful tips on recognizing symptoms early, seeking proper care, and supporting aging loved ones through their eye health journey. Whether you're caring for an aging parent or noticing changes in your own vision, this episode is a must-listen for understanding how to keep your eyes—and your family—focused and healthy. #AgingEyes #SeniorVisionHealth #EyeHealthAwareness #Cataracts #GlaucomaAwareness #Presbyopia #Floaters #Conjunctivitis #HealthyAging #CaregiverSupport #ElderCareTips #VisionChanges #FamilyCaregivers #FocusedHealthyFamily #AgingParents

In this edition of The Rob & Jai Show, Paul Smith, President & COO of Orasis Pharmaceuticals, joins Dr. Rob Rothman and Dr. Jai Parekh for a compelling conversation on his career path and the commercialization of Qlosi™—a novel, FDA-approved, low-dose pilocarpine eye drop for the treatment of presbyopia.With more than two decades of experience across Alcon, Novartis, and now Orasis, Smith reflects on his unique career trajectory from tech startups to ophthalmic leadership, the importance of cross-functional experience, and how a shared vision with founder & CEO Elad Kedar led him to the helm of a company now reshaping the presbyopia landscape.In this episode, you'll learn:Why Qlosi™ was formulated at the lowest approved concentration of pilocarpine to prioritize safety, tolerability, and functional vision.How Orasis is differentiating its launch by learning from past category efforts and focusing on real-world expectations and patient needs.The company's go-to-market strategy, including a hybrid access model and the role of optometry in driving adoption.Why Paul believes innovation in eye care thrives on collaboration, humility, and continuous learning.What makes presbyopia such a powerful entry point into the broader continuum of vision care.With a clear mission, strong leadership, and a product designed with patients in mind, Orasis is setting a new standard in treating one of the most common unmet needs in eye care.Don't miss this thoughtful and inspiring discussion—subscribe to the OIS Podcast today to stay ahead of what's next in ophthalmic innovation!

Video Version Available on YouTube! In this episode of New Insight, host Veeral Sheth, MD, MBA, director of clinical research at University Retina and Macula Associates, explored the approval and impending launch of Qlosi (pilocarpine HCL ophthalmic solution) 0.4%, a groundbreaking pharmacologic option for managing presbyopia, with Elad Kedar, MBA, chief executive officer of Orasis Pharmaceuticals. A condition that affects nearly all adults as they age, presbyopia is characterized by the gradual loss of near vision due to reduced lens elasticity. Sheth and Kedar highlighted the significance of finding non-invasive treatment options for this pervasive issue, given the limitations of traditional solutions like reading glasses or surgical interventions. In October 2023, the US Food and Drug Administration (FDA) approved Qlosi, a preservative-free, low-dose eye drop for presbyopia, based on strong efficacy, safety, and tolerability data reported in the pivotal Phase 3 NEAR-1 and NEAR-2 clinical trials. On Day 8, patients treated with Qlosi achieved statistically significant ≥3-line gain in distance-corrected near visual acuity (DCNVA) and no loss of ≥1-line in distance visual acuity. Sheth and Kedar delved into Qlosi's innovative mechanism of action, emphasizing how it leverages a unique pharmacologic approach to improve near vision. By modulating pupil dynamics, Qlosi enhances the depth of focus, effectively allowing patients to perform near-vision tasks without additional aids. Together, Sheth and Kedar walked through the drug's clinical development journey, highlighting his journey through the founding of Orasis and the company's name in Greek, meaning “good vision or sight.” The discussion included insights into the populations most likely to benefit from Qlosi and the practical considerations for prescribing. Sheth offered a nuanced take on how this therapy could fit into the broader landscape of presbyopia management, addressing questions about patient education, adherence, and expectations. Sheth also shared his perspective on the potential impact of Qlosi on clinical practice, noting that its ease of use and non-invasive nature could appeal to both patients and providers. He reflected on how treatments like Qlosi are part of a broader trend toward personalized medicine, focusing on solutions that improve the quality of life for aging populations. This episode concluded with a thoughtful look at future research directions and the impending launch of Qlosi. Expected soon, Kedar expressed an interest in sharing more details on the product and its position in the presbyopia treatment landscape once the drug comes to market. Every episode of New Insight is available on HCPLive.com. Watch full episodes on our YouTube channel and listen wherever you get your podcasts. Direct all podcast-related inquiries to show producer Connor Iapoce (ciapoce@mjhlifesciences.com) and keep an eye out for more from New Insight! Key Episode Timestamps 00:05 Introduction to Elad Kedar and Orasis 04:34 Orasis' Journey and Initial Development 06:45 Elad Kedar's Background and Company Growth 08:36 Transition from Product Development to Team Building 11:42 Phase Three Study Results and Efficacy 13:39 Safety, Comfort, and Tolerability 15:00 Genesis of the Company Name Orasis 18:26 Challenges and Strategic Planning 21:57 Market Position and Future Outlook 27:27 Conclusion and Future Plans

LNZ100 represents a new generation of miotic eye drops, which, unlike its predecessors, is not based on pilocarpine. Instead, it uses aceclidine, a unique muscarinic agonist selective for the iris's smooth muscle, facilitating pupil constriction with negligible influence on the ciliary muscle. This distinction is essential to achieve a smaller pinhole pupil without a myopic shift. 

In this episode of the ESCRS IME podcast series on refractive IOLs, Drs. Joaquín Fernández and Gerd Auffarth discuss the growing use of presbyopia-correcting IOLs, highlighting the benefits of emerging lens options. They emphasize the importance of proper lens selection, patient education, and managing expectations for spectacle independence. Additionally, they share recommendations when selecting trifocal lenses and offer key post-operative strategies to optimize outcomes and enhance patient satisfaction. Don't forget to listen to the other insightful podcasts in this series! Independent medical education supported by Alcon (Platinum), J&J Vision (Bronze) and Zeiss (Bronze).

In this episode of the ESCRS IME podcast series on refractive IOLs, Drs. Gerd Auffarth and Joaquín Fernández discuss effective strategies for educating cataract patients about presbyopia-correcting lenses. They emphasize the importance of evidence-based communication and shared decision-making. Drs. Auffarth and Fernández also offer valuable insights on lens selection, ensuring patients are fully informed about costs and potential risks. Additionally, they address how to manage patient dissatisfaction, even after thorough preoperative counseling. Be sure to listen to the other insightful podcasts in this series! Independent medical education supported by Alcon (Platinum), J&J Vision (Bronze) and Zeiss (Bronze).

In this episode of the ESCRS IME podcast series on refractive IOLs, Prof. Thomas Kohnen and Dr. Basak Bostanci discuss the critical role of precise preoperative measurements in cataract surgery with presbyopia-correcting lenses to prevent postoperative refractive surprises. They explain how residual refractive errors can have a significant impact on patient vision and satisfaction. The discussion also covers common pitfalls that can lead to postoperative refractive issues and offers practical strategies for avoiding them. Be sure to listen to the other informative podcasts in this series! Independent medical education supported by Alcon (Platinum), J&J Vision (Bronze) and Zeiss (Bronze).

In this episode, Ayesha spoke with AnnMarie Hipsley, DPT, PhD, CEO and founder of Ace Vision Group, an ophthalmic laser device company that is bringing touchless eye laser therapy to patients with age-related vision loss. Dr. Hipsley is a vision scientist, inventor, entrepreneur, author and speaker on ocular biomechanics and the biomechanical rejuvenation of the aging eye. She invented an innovative touchless laser system and a laser microporation system for the treatment of presbyopia. Presbyopia is an age-related condition in which the eye gradually loses its ability to focus on close objects due to natural aging of the lens inside the eye. It typically begins to affect individuals around the age of 40 and continues to progress until around age 65. Dr. Hipsley is passionate about educating the health care space on the global burden of uncorrected presbyopia, particularly the socioeconomic and quality of life implications of the condition. Over the past 25 years, she has trained more than 100 ophthalmic surgeons worldwide in using near-infrared lasers for tissue microporation. Tune into the episode to hear more about Dr. Hipsley and Ace Vision Group's innovative solutions for presbyopia. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

Presbyopia, typically beginning in the late 30s, can hinder athletes who rely on quick, precise focus shifts. For shooters, this condition impacts contrast sensitivity, glare tolerance, and near-vision clarity. The Bausch + Lomb family of lenses—INFUSE®, ULTRA®, and Biotrue® ONEday—offers effective solutions, helping presbyopic shooters maintain peak visual performance.

If you're ready to upgrade your vision, you'll want to hear what Holistic Vision Coach Claudia Muehlenweg has to share. In this episode, Claudia reveals how menopausal women can naturally improve their eyesight without relying on glasses or contacts. She explains how simple habits like blinking, natural sunlight, and using your peripheral vision can boost your eye health and shares screen-time strategies to protect your vision in a tech-heavy world. Her personal story of overcoming childhood vision challenges is inspiring and shows the powerful connection between mental, emotional, and physical vision health.   Claudia breaks down the key elements you need to know if you're worried about eye strain, screen exposure, or age-related vision changes. With over 20 years of experience helping people see clearly without corrective lenses, she's packed this episode with actionable tips. From understanding the role of screen use to the importance of peripheral vision, this episode equips you with practical tools to reduce dependency on glasses and sharpen your sight naturally.   Don't forget to take my FREE Hormone Quiz if you've been feeling off. Discover what's really going on with your hormones and get a personalized report—visit https://bit.ly/3wNJOec. Plus, grab my FREE E-book, A Woman's Guide to Kick-Ass Sleep, to uncover the secrets to sound sleep after 40 at https://bit.ly/4cblYcT. Your best sleep and vision await!   Key Takeaways: [05:23] Not wearing glasses improved Claudia's vision strength. [07:02] Presbyopia causes near vision decline in the forties. [10:39] Monovision: one eye for distance, one for near. [14:26] Astigmatism is linked to postural habits and computers. [17:59] Vision can improve unexpectedly in natural environments. [20:18] Improved vision by noticing daily task effects. [23:36] Morning sunlight benefits circadian rhythm, sleep, and eyes. [28:17] Tunnel vision from focusing on central vision. [29:24] A client's brain couldn't process open road travel. [32:54] Nearsightedness is linked to feeling safe in close-up. [36:29] Fovea lutea: sharp vision, macular degeneration effects. [39:17] Relieve dry eyes with a palming relaxation technique. [42:50] Holistic vision coach with wellness guides online.   Memorable Quotes: "People do not think about their peripheral vision. I said it's just basically more. The word for visual acuity means how sharp you see, right? 2020 or whatever. But there's so much more in vision. There's the peripheral vision, the binocular vision, how the eyes work together, the night vision, the color vision, all these things have to work together to give you optimal vision." — Claudia Muehlenweg "When you go on your next walk, notice when you go up, it seems like the room goes down. Obviously, you are the one moving, but it's that sensation that everything is always fluid and moving. And that might initially be when you're staring, when you're used to that strain with the glasses that might feel very unsettling. But the more you can relax into that, the better your vision will get." — Claudia Muehlenweg Links Mentioned: FREE Hormone Quiz: https://bit.ly/3wNJOec FREE E-book “A Woman's Guide to Kick-Ass Sleep”: https://bit.ly/4cblYcT 10 Computer Eye Strain Hacks Guide: https://www.naturallyclearvision.com/computer-eye-strain-hacks-1   Connect with Claudia Muehlenweg: Website: https://naturallyclearvision.com/ Instagram: https://www.instagram.com/holisticvisioncoach/ Facebook: https://www.facebook.com/ClaudiaMuehlenweg LinkedIn: https://www.linkedin.com/in/claudiamuehlenweg/ YouTube: https://www.youtube.com/c/BatesvisionLosAngeles   Connect with Betty Murray: Living Well Dallas Website: https://www.livingwelldallas.com/ Hormone Reset Website: https://hormonereset.net/ Betty Murray Website: https://www.bettymurray.com/ Facebook: https://www.facebook.com/BettyAMurrayCN/ Instagram: https://www.instagram.com/bettymurray_phd/   Produced by Evolved Podcasting: www.evolvedpodcasting.com

If you're ready to upgrade your vision, you'll want to hear what Holistic Vision Coach Claudia Muehlenweg has to share. In this episode, Claudia reveals how menopausal women can naturally improve their eyesight without relying on glasses or contacts. She explains how simple habits like blinking, natural sunlight, and using your peripheral vision can boost your eye health and shares screen-time strategies to protect your vision in a tech-heavy world. Her personal story of overcoming childhood vision challenges is inspiring and shows the powerful connection between mental, emotional, and physical vision health.   Claudia breaks down the key elements you need to know if you're worried about eye strain, screen exposure, or age-related vision changes. With over 20 years of experience helping people see clearly without corrective lenses, she's packed this episode with actionable tips. From understanding the role of screen use to the importance of peripheral vision, this episode equips you with practical tools to reduce dependency on glasses and sharpen your sight naturally.   Don't forget to take my FREE Hormone Quiz if you've been feeling off. Discover what's really going on with your hormones and get a personalized report—visit https://bit.ly/3wNJOec. Plus, grab my FREE E-book, A Woman's Guide to Kick-Ass Sleep, to uncover the secrets to sound sleep after 40 at https://bit.ly/4cblYcT. Your best sleep and vision await!   Key Takeaways: [05:23] Not wearing glasses improved Claudia's vision strength. [07:02] Presbyopia causes near vision decline in the forties. [10:39] Monovision: one eye for distance, one for near. [14:26] Astigmatism is linked to postural habits and computers. [17:59] Vision can improve unexpectedly in natural environments. [20:18] Improved vision by noticing daily task effects. [23:36] Morning sunlight benefits circadian rhythm, sleep, and eyes. [28:17] Tunnel vision from focusing on central vision. [29:24] A client's brain couldn't process open road travel. [32:54] Nearsightedness is linked to feeling safe in close-up. [36:29] Fovea lutea: sharp vision, macular degeneration effects. [39:17] Relieve dry eyes with a palming relaxation technique. [42:50] Holistic vision coach with wellness guides online.   Memorable Quotes: "People do not think about their peripheral vision. I said it's just basically more. The word for visual acuity means how sharp you see, right? 2020 or whatever. But there's so much more in vision. There's the peripheral vision, the binocular vision, how the eyes work together, the night vision, the color vision, all these things have to work together to give you optimal vision." — Claudia Muehlenweg "When you go on your next walk, notice when you go up, it seems like the room goes down. Obviously, you are the one moving, but it's that sensation that everything is always fluid and moving. And that might initially be when you're staring, when you're used to that strain with the glasses that might feel very unsettling. But the more you can relax into that, the better your vision will get." — Claudia Muehlenweg Links Mentioned: FREE Hormone Quiz: https://bit.ly/3wNJOec FREE E-book “A Woman's Guide to Kick-Ass Sleep”: https://bit.ly/4cblYcT 10 Computer Eye Strain Hacks Guide: https://www.naturallyclearvision.com/computer-eye-strain-hacks-1   Connect with Claudia Muehlenweg: Website: https://naturallyclearvision.com/ Instagram: https://www.instagram.com/holisticvisioncoach/ Facebook: https://www.facebook.com/ClaudiaMuehlenweg LinkedIn: https://www.linkedin.com/in/claudiamuehlenweg/ YouTube: https://www.youtube.com/c/BatesvisionLosAngeles   Connect with Betty Murray: Living Well Dallas Website: https://www.livingwelldallas.com/ Hormone Reset Website: https://hormonereset.net/ Betty Murray Website: https://www.bettymurray.com/ Facebook: https://www.facebook.com/BettyAMurrayCN/ Instagram: https://www.instagram.com/bettymurray_phd/   Produced by Evolved Podcasting: www.evolvedpodcasting.com

The conversation delved into the science behind aceclidine, its advantages over existing treatments like pilocarpine, and its potential to revolutionize presbyopia management.

As we age, we collect experiences. Until we reach the smug summit of "been there, done that." That's when each new experience feels like the same old experience, repeating. Every experience becomes tame and tedious. And, dare I say it, boring!

Natasha (Tasha) Hindman, O.D., has been practicing optometry since 2003. She graduated Magna Cum Laude with a B.S. in Biochemistry at Roberts Wesleyan College in Rochester, NY, where she also played basketball, captaining her team. She then attended Pennsylvania College of Optometry (now Salus University) where she received a BS in Visual Science as well as her doctorate (OD). At Scott and Christie Eyecare Associates, Dr. Hindman serves as the Director of Clinical Research for their Eye Research Institute. In this role, she serves effectively to advance the future technology of eyecare through clinical trials with a focus on dry eye, glaucoma, blepharitis, presbyopia, myopia and allergies.

Milton M. Hom, OD, FAAO. practices in Azusa, CA, USA. He is an internationally recognized expert and researcher in therapeutics, dry eye, presbyopia, contact lenses, and allergy. He is also co-medical director for the multi-site Neurosensory Abnormalities in SymptomAtic Ocular Surface Patients (NASA) study. Dr. Hom has written 4 books and published over 200 papers and peer-reviewed abstracts.

Schneider Self-Healing Method combines breathing, unique bodywork, movement and visualization techniques that can help anyone to become more aware of their own body and be empowered to take charge of their own healing. His method is effective to help people to see well (with or without glasses), get rid of computer stress syndrome, help overcome nearsightedness(myopia), teach to not need readers, prevent macular degeneration, glaucoma, cataracts, retinal detachment and others. Meir applied his Method of Self-Healing to help others who suffered from a wide range of degenerative conditions such as polio, muscular dystrophy and multiple sclerosis, in a natural way. Through his methods, you can learn how you can improve your eyesight and how you can move better, prevent most illnesses with simple exercises. This can be done with simple exercises which can be entertaining and pleasurable. You will also learn how flexible your brain is and find new ways to bring out your body's resources in daily life. Other advantages of his methods include: • Reducing computer eyestrain • Overcoming the dependency on glasses • Improving joint mobility • Preventing all back problems • Getting rid of the nagging back pain • Overcoming headaches

• Book a free consultationhttps://calendly.com/d/zzg-xx9-gjd • Mandarin Lessons: https://yunfei.world/languages/learn-mandarin/ • Email: zhuimin9698@gmail.com • IG@ huimin_taiwan_mandarin • 留言告訴我你對這一集的想法： https://open.firstory.me/user/ckq9bl3vd660p0805d1apvgrd/comments • Paypal: PayPal.Me/ZhanghuiminTW 生詞表: 1. 老花眼(老花) , Lǎohuāyǎn (lǎo huā) , Presbyopia (presbyopia) 2. 模糊 , móhú , Vague 3. 加上 , jiā shàng , plus, in addition, furthermore 4. 反光 , fǎnguāng , Reflection 5. 儘量 , jǐnliàng , try your best 6. 螢幕 , yíngmù , screen 7. 原因 , yuányīn , reason 8. 眼鏡行 , yǎnjìng xíng , glasses shop 9. 近視 , jìnshì , Shortsighted 10. 換成 , huàn chéng , Replace with 11. 多焦鏡片 , duō jiāo jìngpiàn , multi-focus lenses 12. 變色 , biànsè , Discoloration 13. 陽光很強 , yángguāng hěn qiáng , The sun is very strong 14. 暗暗的 , àn'àn de , dark 15. 灰色 , huīsè , grey 16. 鏡片 , jìngpiàn , lens 17. 突然 , túrán , Suddenly 18. 陽光很亮 , yángguāng hěn liàng , The sun is very bright 19. 醜 , chǒu , ugly 20. 好險 , hǎo xiǎn , so close, fortunately 21. 上半部分 , shàng bàn bùfèn , the top half 22. 下半部分 , xià bàn bùfèn , the down half 23. 鏡框 , jìngkuāng , the frame of the glasses 24. 省鏡框的錢 , shěng jìngkuāng de qián , Save money on frames 25. 備用眼鏡 , bèiyòng yǎnjìng , spare glasses 26. 疲勞 , píláo , fatigue 27. 適應 , shìyìng , adapt to 28. 驗光師 , yànguāng shī , optometrist 29. 膠帶 , jiāodài , adhesive tape 30. 分開來戴 , fēnkāi lái dài , Wear them separately 31. 200度 , 200 dù , 200 degrees 32. 困擾 , kùnrǎo , Troubled 33. 隱形眼鏡 , yǐnxíng yǎnjìng , contact lenses 34. 想像那個畫面 , xiǎngxiàng nàgè huàmiàn , Imagine that scene 35. 打扮 , dǎbàn , dress up Powered by Firstory Hosting

In this episode of the IME podcast on RIOLs, Dr. Basak Bostanci and Prof. Thomas Kohnen discuss available presbyopia-correcting IOLs and critical factors in selecting the most suitable lens for each patient. They highlight the importance of considering the patient's preference for spectacle independence, addressing ocular surface conditions, and potential optical symptoms to maximize patient satisfaction. Independent medical education supported by Alcon (Gold), J&J Vision (Gold) and Zeiss (Bronze).

Dr. Marc Odrich is Chief Medical Officer at LENZ therapeutics and has decades of experience in private practice, teaching, and medical research that contributes to LENZ Therapeutics success by driving the clinical trial and approval of our novel products. His expertise in authoring and directing over 25 clinical trials throughout his career makes him uniquely qualified to execute the approval process. In addition to his duties as Chief Medical Officer, Dr. Odrich is an Associate Professor of Ophthalmology at the University of Virginia, where he practices and teaches Clinical Ophthalmology specializing in Refractive Surgery and Ocular Surface Disease. He is also the Chief Medical Officer for TearSolutions, Inc., a startup in clinical trials for a new drug developed for dry eye disease. In addition, he is a consultant and member of the Board of Directors for CXLO, Inc., a developer of an innovative treatment for keratoconus and other corneal ectasias, as well as a consultant and medical monitor for Johnson & Johnson's refractive products. Previously, he played pivotal roles in the development and commercialization of the Excimer and Femto lasers as Medical Director at Visx. Dr. Odrich is a graduate of Columbia College and received his medical degree from Columbia University College of Physicians and Surgeons. He completed an internship in internal medicine at Yale's Danbury Hospital before moving to pursue his residency at Columbia's Harkness Eye Institute. Odrich then completed a two-year fellowship focused on cornea and external disease at Harvard's Massachusetts Eye and Ear Infirmary.

Today, you'll learn about an artificial reef that could save the shore from storms, how simply owning a pair of glasses can make you earn more income, and how air conditioners could help CSI detectives solve crimes. Artificial Reef “Artificial reef designed by MIT engineers could protect marine life, reduce storm damage.” by Jennifer Chu. 2024. “Coastal Protection.” Coral Reef Alliance. 2024. “Architected materials for artificial reefs to increase storm energy dissipation.” by Edvard Ronglan, et al. 2024. Glasses & Income “Having the right glasses could boost earning power by a third, Bangladesh study shows.” by Sarah Johnson. 2024. “The effect on income of providing near vision correction to workers in Bangladesh: The THRIVE (Tradespeople and Hand-workers Rural Initiative for a Vision-enhanced Economy) randomized controlled trial.” by Farzana Sehrin, et al. 2024. “Presbyopia.” Mayo Clinic. 2021. “The Global Burden of Potential Productivity Loss from Uncorrected Presbyopia.” by Kevin D. Frick, et al. 2015. AC DNA “Cold case: DNA in airconditioners to place suspects at the scene of a crime.” by Ben Coxworth. 2024. “Up in the air: Presence and collection of DNA from air and air conditioner units.” by Mariya Goray, et al. 2024. Follow Curiosity Daily on your favorite podcast app to get smarter with Calli and Nate — for free! Still curious? Get exclusive science shows, nature documentaries, and more real-life entertainment on discovery+! Go to https://discoveryplus.com/curiosity to start your 7-day free trial. discovery+ is currently only available for US subscribers. Hosted on Acast. See acast.com/privacy for more information.

In this episode of the IME podcast on RIOLs Dr. Basak Bostanci and Susana Marcos discuss the importance of intermediate vision and how to integrate enhanced monofocal IOLs into the presbyopia treatment strategy. Independent medical education supported by Alcon (Gold), J&J Vision (Gold) and Zeiss (Bronze).

In this episode of the IME podcast on RIOLs Dr. Basak Bostanci and Susana Marcos focus on how to optimize education in patients interested in presbyopia-correction. Independent medical education supported by Alcon (Gold), J&J Vision (Gold) and Zeiss (Bronze).

There are lots of ways to connect with our faith community. Be sure to visit our website, fpcrichmond.org, to learn more. Be sure to check out this week's sermon video here!

Dr Michael Lange hosts "ask the dr" today with his guest Michael Walach. Michael is an optical lens industry veteran and expert. The evolution of presbyopia spectacle lens correction is here today with the all new Eyefocal Omni NAL. NAL stands for natural accommodation lens and was invented by Michael Walach. NAL is a true multifocal lens that provides correction from infinity to near in one continuous individually adjusted power curve. Eyefocal Omni NAL is the next generation in lens concept for the over 40 crowd with presbyopia. The Lange Eye Institute in The Villages Florida is one of the first in the country to offer this new Eyefocal Omni NAL concept. Progressive lenses have been around for over 60 years and have not changed a significant amount in this time period. The NAL is a revolutionary new lens concept that allows people to see clearly in the distance and up close with no peripheral distortion or "swim" sensations. This new lens concept also reduces human error in the Measurment's for the progressive lenses since no seg height measurement is necessary with this lens. Dr Lange feels this new NAL will be a much better option for patients with macular degeneration or patients with visual field loss from a stroke or traumatic brain injury. Both Michael Walach and Dr Lange feel this NAL will be a big advantage for anyone playing sports over a progressive lens. Today's show was upbeat, educational and had lots of good live calls, Dr Susan Summerton called in from a conference and updated everyone on the latest in eye care technology. Dr Lange also briefly mentioned the all new Fortifeye Next Gen Macular Defense supplement is now available.Support the show: https://www.drmichaellange.com/category/ask-the-doctor/See omnystudio.com/listener for privacy information.

On this week's Biotech Hangout, Chris Garabedian, Josh Schimmer, Dawn Bell, Paul Matteis and Yaron Werber discuss the white hot ADC space as Genmab pays $1.8 billion to acquire Profound Bio and its ADC portfolio, Ispen's $900 million pact with Sutro and Merck KGaA's $1.4 billion ‘BioBucks' AI deal with Caris Discovery. The hosts also cover the week's big private deals including Metsera $350 million funding, Oruka's $275 million PIPE, Obsidian's $175 million Series C, Alterome's $132 million Series B and Neurosterix $63m spinout from Addex. The group also discusses Amylyx's decision to withrawl ALS drug and Acorda and Eiger both file for bankruptcy. On the data and regulatory front, the hosts discuss Roivant's positive Phase 2 study results in eye disease, Gritstone's Phase 2 neoantigen cancer vaccine results, LENZ's Phase 3 data for Presbyopia and Vertex's Phase 3 kidney disease trial. *This episode aired on April 5, 2024.

Join us this week on the OIS podcast as host Carey Powers sits down with Dr. Paul Karpecki to explore the latest advancements in presbyopia treatment strategies. Here's what you can expect from this insightful conversation:Insider Insights: Dr. Karpecki shares insider insights gleaned from his extensive clinical experience and research in the field of presbyopia treatment.Financial Potential: Discover the potential for unprecedented financial gains in the rapidly evolving market of presbyopia treatment.Cutting-Edge Strategies: Uncover the latest cutting-edge strategies and developments in the treatment of presbyopia, offering hope and solutions to millions affected by this common eye condition.Tune in to this episode for an in-depth look at the future of presbyopia treatment and the exciting opportunities it presents!

For more information about Optometry Giving Sight, visit: https://givingsight.org/Key Moments:2:41 Dr. Alan Glazier's background story4:30 The launch of a “little group” called ODs on Facebook7:12 Blazing your own trail in optometry9:38 Managing the largest online community of optometrists11:15 Being mission led with ODs on Facebook12:10 Giving back with Optometry Giving Sight15:33 Expanding on ODs on Facebook to fill unmet needs  17:39 Presbyopia research  29:12 Protecting your ideas with patents34:58 Accepting how each OD choices to practice Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.

Come on by & knock on my door if you're single AND attractive. --- Send in a voice message: https://podcasters.spotify.com/pod/show/bling-viera/message

In this ESCRS IME podcast on Refractive IOLs, Profs. Drs. Burkhard Dick and Beatrice Cochener discuss various contributing factors to achieve the best outcomes with presbyopia correction in cataract surgery. To hear more about this topic, make sure to listen the other podcasts in this series. Independent Medical Education supported by Alcon (Platinum), Johnson & Johnson (Gold), Bausch + Lomb (Bronze).

In this ESCRS IME podcast on Refractive IOLs, Profs. Drs. Beatrice Cochener and Burkhard Dick focus on patient communication and how to match IOL technology to the patient's needs and expectations. To hear more about this topic, make sure to listen the other podcasts in this series. Independent Medical Education supported by Alcon (Platinum), Johnson & Johnson (Gold), Bausch + Lomb (Bronze).

Episode 31 of the ESCRS Eye Journal Club  with Imran Yusuf and Artemis Matsou was held on August 16, 2023 at 19:30 CEST. The guest experts are Professor Anders Behndig and Professor Pavel Stodulka who discuss the following paper: Ten-year outcomes of pseudophakic mini-monovision correction of hyperopic presbyopia.  https://journals.lww.com/jcrs/Citation/2023/06000/FS_LASIK_for_the_treatment_of_moderate_to_high.4.aspx Wróbel-Dudzińska, Dominika MD, PhD; Moura-Coelho, Nuno MD, PhD; Palma-Carvajal, Francisco MD; Zebdeh, Abdulah MD; Manero, Felicidad MD; Güell, José Luis MD, PhD   DOI LINK: 10.1097/j.jcrs.0000000000001116

In this episode, my guest is Jeffrey Goldberg, MD, PhD, professor and chair of the department of ophthalmology at the Byers Eye Institute at Stanford University. His clinical and research efforts focus on retinal and optic nerve diseases such as glaucoma and discovering stem cell and nanotechnology treatments to cure blindness. We discuss how to maintain and improve eye health throughout life, the advantages and disadvantages of corrective lenses, including if you should wear “readers,” the use and risks of contact lenses, considerations for LASIK eye surgery, floaters, dry eye, the importance of sunlight and UV protection and specific exercises to improve eye and vision health. Dr. Goldberg also explains age-related conditions: cataracts, glaucoma, macular degeneration and diabetic retinopathy; and the behavioral and supplementation-based, prescription and surgical tools used to promote eye health. This episode provides essential tools for listeners of any age and background to maintain eye health and offset vision loss. For the full show notes, visit hubermanlab.com. Thank you to our sponsors AG1 (Athletic Greens): https://athleticgreens.com/huberman Maui Nui Venison: https://mauinuivenison.com/huberman LMNT: https://drinklmnt.com/huberman  Eight Sleep: https://eightsleep.com/huberman  InsideTracker: https://insidetracker.com/huberman  Momentous: https://livemomentous.com/huberman Timestamps (00:00:00) Dr. Jeffrey Goldberg (00:03:08) Sponsors: Maui Nui, LMNT, Eight Sleep (00:06:29) Childhood & Eye Exams (00:11:36) Eye Misalignment & Recovery (00:20:38) Myopia (Near-Sightedness), Children & Sunlight (00:30:04) Sponsor: AG1 (Athletic Greens) (00:31:18) Eye Safety & Protection; Eye Hygiene (00:40:07) Adults & Eye Exams; Optometrist vs Ophthalmologist (00:46:35) Presbyopia (Age-Related Vision Decline), Reading Glasses (00:54:54) Reading Glasses: Use & Recommendations (00:58:34) Night Vision & Glasses (01:02:55) Sponsor: InsideTracker (01:03:54) Corrective Eye Glasses, Exercises (01:09:52) Near-Far Exercise & Presbyopia; Smooth Pursuit Exercise & Concussion (01:13:25) Supranormal Vision & Performance Training (01:19:11) 20/20 Vision; Visual Acuity (01:24:51) Contact Lenses: Use, Risks & Aging (01:31:34) UV Protection & Cataracts, “Blue Blockers” (01:38:20) Light Sensitivity & Eye Color (01:40:29) LASIK Eye Surgery (01:46:26) Dry Eye, Tears & Age (01:53:24) Dry Eye, Serum Tears & Preservative-Free Artificial Tears; PRP (02:00:46) Vision Loss: Cataracts, Glaucoma (02:09:23) Age-Related Macular Degeneration, Dry & Wet Forms (02:14:02) Diabetic Retinopathy, Type I vs Type II Diabetes (02:18:54) Diabetic Retinopathy Treatment, Blood Pressure (02:22:17) Glaucoma Screening & Treatment (02:28:07) Smoking, Vaping & Vision Diseases; Cannabis & Eye Pressure (02:35:13) Eye Pressure & Sleep Position (02:37:48) Macular Degeneration, Optic Neuropathies & Red-Light Therapy (02:42:23) “Floaters” (02:45:29) Eye Twitching (02:48:10) AREDS2 Supplementation & Age-Related Macular Degeneration (02:53:39) Glaucoma & Vitamin B3 Supplementation (02:58:42) Retinal Imaging & Neurodegeneration Screening, Multiple Sclerosis (03:06:30) Zero-Cost Support, YouTube Feedback, Spotify & Apple Reviews, Sponsors, Momentous, Social Media, Neural Network Newsletter Title Card Photo Credit: Mike Blabac Disclaimer

In this ESCRS IME podcast on Refractive IOLs, Drs. Oliver Findl and Thomas Kohnen discuss how to communicate effectively with cataract patients seeking spectacle independence. To hear more about this topic, make sure to listen the other two podcasts in this series. Independent Medical Education supported by Alcon (Platinum), J&J Vision (Gold) and Zeiss (Bronze).

In this ESCRS IME podcast on Refractive IOLs, Drs. Oliver Findl and Thomas Kohnen discuss post-operative outcomes and satisfaction in cataract patients seeking spectacle independence. To hear more about this topic, make sure to listen the other two podcasts in this series. Independent Medical Education supported by Alcon (Platinum), J&J Vision (Gold) and Zeiss (Bronze).

In this ESCRS IME podcast on Refractive IOLs, Drs. Oliver Findl and Thomas Kohnen discuss key pre-operative measurements and considerations for cataract patients seeking spectacle independence. To hear more about this topic, make sure to listen the other two podcasts in this series. Independent Medical Education supported by Alcon (Platinum), J&J Vision (Gold) and Zeiss (Bronze).

Kerry Giedd, OD, of Eola Eyes in Orlando, Florida, talks about the opportunities with presbyopes and emerging presbyopes. With more treatment and contact lens options available today, there's more that optometrists can do for their patients. 

Today I'm bringing you behind the scenes of a session I did with somebody who's dealing with nearsightedness and presbyopia. He's a bit frustrated with the reading glasses because they're making his eyes worse. So, I unpack his visual situation and we get to the root cause of his visual issues. Once we get to the root cause, we can begin to work on his visual transformation and we can work toward getting rid of his glasses. Enjoy the show.

At some point after 40, each of us will experience presbyopia, or difficulty focusing on nearby objects. We may also have trouble with night vision, suffer from dry eye, or deal with other age- and hormone-related conditions. Optometrist Dr. Surveen Singh fills us in on the latest treatments that can help with these issues, as well as the best protective measures to keep our eyes healthy well into old age. We also discuss computer use and how that's affecting not only our eyes, but our kids', whether or not blue-light glasses actually work, which eye symptoms should be viewed as an emergency, the beauty product that may unintentionally protect our vision, and the nasty habit some of us had in the 90s that (hopefully) we've all broken by now. Full show notes available at Morebeautifulpodcast.com.    

Today on the show we welcomed Drs. Melissa Barnett and Pamela Lowe. We talked about Presbyopia and all the options we have for our patients from pharmaceuticals, surgery, contact lenses and more! We also dove deeper into how we can best communicate with our presbyopic patients about their eye health and how to be preventative.  For our listeners, use the code 'EYECODEMEDIA22' for 10% off at check out for our Premiere Billing & Coding bundle or our EyeCode Billing & Coding course. Sharpen your billing and coding skills today and leave no money on the table!  Show Sponsors: CooperVision MacuHealth EssilorLuxottica Guest Bios: Dr. Lowe is currently Director/President of Professional Eye Care Center, Incorporated, a private practice she founded in 1992 on Chicago's Northwest Side. She received her Bachelor of Science degree from Loyola University of Chicago in 1984 and graduated with honors from the Illinois College of Optometry in 1988. The college named her the Alumnus of the Year in 2002. Dr. Lowe is active in organized optometry and is a Past President of the Illinois Optometric Association. Dr. Lowe was awarded Illinois's Young Optometrist of the Year in 1995 and Optometrist of the Year in 2006. She has been a career long member of the American Optometric Association serving as a Past Chair of the AOA Contact Lens and Cornea Section and currently serves as Chair of the Strategic Communications Committee and is a Keyperson for AOA Advocacy. She is a Fellow with the American Academy of Optometry and a Diplomate of the American Board of Optometry. She serves as VisionSource Medical Director in Chicagoland where she is an administrator for over sixty independent private practice locations. Dr. Lowe has lectured and authored on many topics including retinal disease, cataract extraction, laser vision correction, and currently travels throughout the country speaking on new contact lens innovations, technologies for early detection of macular degeneration, dry eye disease strategies and myopia management.  Dr. Melissa Barnett is a principal optometrist at the University of California, Davis Eye Center in Sacramento and Davis, California. She is an internationally recognized key opinion leader, specializing in dry eye disease, specialty contact lenses, and presbyopia. Dr. Barnett lectures globally and publishes extensively on topics including dry eye, anterior segment disease, contact lenses, presbyopia, and creating a healthy balance between work and home life for women in optometry. She is Immediate Past Chair of the American Optometric Association Contact Lens and Cornea Section, a Fellow of the American Academy of Optometry, a Diplomate of the American Board of Certification in Medical Optometry, a Fellow and Global Ambassador of the British Contact Lens Association, serves on the Board of the Gas Permeable Lens Institute, International Society of Contact Lens Specialists and is Past President of The Scleral Lens Education Society. Drs. Melissa Barnett and Lynette Johns authored and edited the book Contemporary Scleral Lenses: Theory and Application with the unique perspectives and contributions of international experts. Dr. Barnett most recently chaired the BCLA CLEAR report on scleral lenses. She is currently serving on the Tear Film & Ocular Surface Society (TFOS): A Lifestyle Epidemic Ocular Surface Disease Workshop. Dr. Barnett was awarded the inaugural Theia Award for Excellence for Mentoring by Women in Optometry. She was granted the Most Influential Women in Optical from Vision Monday in 2019. Dr. Barnett and Dr. Tom Arnold are co-hosts of the popular podcast GlobalEyes. In her spare time, she enjoys cooking, yoga, hiking and spending time with family.  

Please visit answersincme.com/EUA860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in ophthalmology discusses new treatments for patients with presbyopia. Upon completion of this activity, participants should be better able to:Recognize the unmet therapeutic needs with available presbyopia treatments; Describe the evidence for late-stage emerging miotic agents being developed to treat presbyopia; and Outline strategies to individualize treatment selection for patients with presbyopia.

The changes in our metabolism and body systems that we associate with aging  are variable, and manifest at different times in different individuals. Presbyopia, the difficulty in close up focussing that requires us to get reading glasses, may become problematic in the early forties for some, while others may not experience it until much later in life. Other aging associated changes like wrinkles from  loss of elasticity in our skin, thinning, baldness or greying of our hair, or increasing middle-age spread, also become evident in individuals at  different ages. As women, we become accustomed from puberty, to cyclical fluctuations in our physiology associated with  hormonal changes. These effects are magnified as we transition through menopause and peri-menopause too is variable in timing and duration. Today I speak with award-winning Clinician-Scientist, and 40+ year University of British Columbia Endocrinology Professor. Dr. Jerilynn Prior, about the Paradox of Perimenopause. Dr. Prior's research and innovative concepts are changing women's reproduction. She shows that progesterone must be in balance with estradiol for wellbeing and fertility during the premenopausal years,  and for lifelong good health. In an upcoming episode, Part 2 of my conversation with Dr. Prior, we will be discussing healthy aging, the Growing Older Living Younger mission of aging gracefully and living younger, longer. In 2002, Dr. Prior founded the UBC Centre for Menstrual Cycle and Ovulation Research.  She is an internationally recognized thought leader on menstrual cycles, ovulation, perimenopause, menopause, osteoporosis prevention and treatment of night sweats. Her controlled trials show that progesterone decreases menopausal Vasomotor Symptoms of hot flashes and night sweats, and increases bone formation. Learn more about Dr. Prior and the Centre for Menstrual Cycle and Ovulation Research here www.cemcor.ubc.ca Facebook: Centre for Menstrual Cycle and Ovulation Research (https://www.facebook.com/cemcor.research) To discover how to Reset Your Aging Blueprint and create your own roadmap to living younger as you grow older, you can schedule a free Discovery Call with me.  Order your copy of Growing Older Living Younger: The Science of Aging Gracefully and The Art of Retiring Comfortably here and join our private Growing Older Living Younger Community, to meet people, who like you, are discovering and sharing ways to age in great health.

In this episode, we review the high-yield topic of Presbyopia from the Opthalmology section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

Chief Medical Editor Cathleen M. McCabe, MD, hosts a discussion of preferred treatments and patient selection for pharmacologic agents, premium IOL technologies, and refractive procedures with guests Audrey R. Talley Rostov, MD; Brian M. Shafer, MD; Mitchell C. Shultz, MD; Stephen G. Slade, MD, FACS; and Dagny C. Zhu, MD. Revisit the discussion and explore global perspectives in the August issue of CRST, available here: https://crstoday.com/articles/2022-aug/presbyopia-perspectives-a-global-discussion/ 

Story: Forgetfulness and Presbyopia Author: lots_of_oranges_outside Rating: GA Site link: https://archiveofourown.org/works/36222217 Read by: kristinsauter Summary: msr | s11 | Post "Nothing Lasts Forever". Used by the author's permission. The characters in these works are not the property of the Audio Fanfic Podcast or the author and are not being posted for profit.

A new, non-surgical solution to treat presbyopia, the loss of near vision, is available. How does it work and does it help people in their 40s+ read text messages and fine print without reading glasses? Dr. Schumer and Dr. Litzinger provide all the details about this new eye drop and who may benefit most. This episode features audio from ReVision's Patient Education Library, a collection of videos created by our surgeons to share detailed information about vision solutions and to address commonly asked questions. View this and other videos on ReVision's YouTube Channel: https://www.youtube.com/user/ReVisionAdvanced/playlists

Welcome to The Nonlinear Library, where we use Text-to-Speech software to convert the best writing from the Rationalist and EA communities into audio. This is: Cause Exploration Prizes: Could New Technology Help Solve the Glasses Problem?, published by Open Philanthropy on July 12, 2022 on The Effective Altruism Forum. This essay was submitted to Open Philanthropy's Cause Exploration Prizes contest and posted to the Forum with the author's permission. Summary of the problem There are 2.2 billion people in the world who are visually impaired. There are two main causes of visual impairment. The first is medical problems, such as cataracts or vitamin A deficiency, which require surgery or medical treatment to treat them. The second is refractive errors, which means that the eyes are healthy, but the person needs glasses in order to see clearly. Uncorrected refractive errors (URE) are the leading cause of visual impairment worldwide. In 2020, more than 1.1 billion people in the world were visually impaired simply because they did not have access to glasses, and this number is expected to rise to 1.8 billion by 2050. This essay will focus on addressing URE, barriers to providing glasses, and new technology that might greatly expand the scope of care. Refractive errors, such as myopia, hyperopia, astigmatism, and presbyopia, are easily corrected with glasses. Refractive error is an extremely common problem; 75% of American adults wear glasses or contact lenses for correction. In high-income nations, the incidence of visual impairment from uncorrected refractive errors (URE) is less than 10%, since most people have access to glasses through their medical insurance. However, the burden of visual impairment from URE is more than four times greater in low- and middle-income countries compared to high-income countries. In western, eastern and central sub-Saharan Africa, 80% of the population suffers with uncorrected refractive errors. While the global incidence of blindness has decreased in the past 30 years due to improvements in medical treatments of trachoma and river blindness, this has been offset by the increasing age of the population. There has been a shift from medical visual impairment to refractive visual impairment as the leading cause of disability. Presbyopia, which is the need for reading glasses or bifocals, develops in 100% of people by the age of 50. Without reading glasses or bifocals, people over age 50 cannot perform tasks requiring near vision, such as reading, removing pebbles from beans or rice, or spotting holes in their malaria bed net. There are 826 million severely impaired and 1.8 billion moderately impaired people who need, but do not have access to reading glasses, which would allow them to easily perform these tasks. This includes up to 94% of the population in some countries in Africa and Asia. (6, 19) Importance of solving the problem Disability URE is the number one global cause of disability.(4) According to the Global Burden of Disease 2013 study, the global burden of URE was 11.3 million disability-adjusted life years (DALYs). The number of DALYs increased 43% from 1990 to 2013. Highest DALYs (241 DALYs per 100,000) were found in low-income areas, including southeast Asia, eastern Mediterranean, and Africa. Women over the age of 40 had higher DALYs from URE compared to men and younger people. Older people had higher DALYs which increased with age. URE burden is inversely proportional to a country's Human Development Index, so countries with the least-developed health and education provisions were more affected by URE.(5) Morbidity URE is not just about inability to work. Because vision is the dominant of the five senses, people fear blindness more than many lethal conditions such as cancer. Mobility and autonomy are usually dependent on vision. URE is a tremendous hurdle to education, literacy, workforce participation, and social connectedness. People with visual impairment are more likely to be u...

Welcome to the Pain Free for Life podcast. In this episode, Dr. Rob Vanbergen talks with Meggen Harris, A 20-year strategic marketing and communications professional, who discovered Microcurrent and helped change her life for the better. Meggen, around the age of 40, started to have issues with her vision and discovered that she had presbyopia. Presbyopia is a gradual, age-related loss of the eyes' ability to focus actively on nearby objects. This led to Meggen's vision deteriorating to 20/10 vision but with the help of microcurrent she has restored her vision back to 20/20. Microcurrent helps heal the root cause of the issue instead of merely treating the symptoms.  To learn more about Meggen Harris and her work please visit https://www.forbes.com/sites/meggenharris/?sh=588092416a29 Thank you so much for joining us today and listening to the Pain Free for Life podcast. For more information about Dr. Rob Vanbergen and how you can take steps to becoming pain free for life, visit the Pain Free for Life website: https://painfreeforlife.com/

Dr. Rachael specializes in hard-to-fit contact lenses and ocular diseases like Glaucoma, Macular degeneration, Diabetes, and more. She was named 2017 Young Optometrist of the Year, 2018 Young Optometrist of the South, and 2018 Women in Optometry Theia Award.